急性肺栓塞后慢性血栓栓塞性肺动脉高压与肺栓塞后损害:FOCUS研究
FOCUS是一项在德国17家大容量中心开展的前瞻性多中心观察性队列研究,纳入1017例确诊急性症状性肺栓塞的成人患者,随访中位732天。结果显示CTEPH的2年累积发生率为2.3%(1.2-4.4%),而符合预设标准的肺栓塞后损害(PPEI)2年累积发生率达16.0%(95%CI 12.8-20.8%)。PPEI有助于识别随访期间诊断的16例CTEPH中的15例,且与再住院、死亡风险升高及生活质量下降相关。
要点
- 急性肺栓塞后CTEPH 2年累积发生率为2.3%(1.2-4.4%)。
- 符合标准化标准的PPEI 2年累积发生率为16.0%(95%CI 12.8-20.8%)。
- PPEI可识别随访期间16例CTEPH中的15例,支持系统化随访。
核心结论
- 急性肺栓塞后CTEPH的2年累积发生率为2.3%,但按标准化标准诊断的PPEI较为常见。
- 研究结果支持对急性肺栓塞患者进行系统随访,并可能有助于优化指南推荐和肺栓塞后管理流程。
研究设计与样本
- 前瞻性多中心观察性队列研究,在德国17家大容量中心开展。
- 纳入1017例确诊急性症状性肺栓塞的成人连续患者,女性占45%,中位年龄64岁,随访中位732天。
- 采用标准化评估计划和预设的3、12、24个月访视。
主要发现
- 16例(1.6%)诊断为CTEPH,诊断中位时间为129天,估计2年累积发生率为2.3%(1.2-4.4%)。
- 880例可评估PPEI,2年累积发生率为16.0%(95%CI 12.8-20.8%)。
- PPEI识别了随访期间诊断的16例CTEPH中的15例,CTEPH vs 无CTEPH的风险比为393(95%CI 73-2119)。
- 与无PPEI患者相比,PPEI患者再住院和死亡风险更高,生活质量更差。
关键数值与推荐
- CTEPH诊断基于随访评估,2年累积发生率为2.3%(1.2-4.4%)。
- PPEI定义为随访期间持续或恶化的临床、功能、生化和影像学参数组合,2年累积发生率为16.0%(95%CI 12.8-20.8%)。
临床怎么用
- 对急性肺栓塞患者应考虑系统随访以早期识别CTEPH和PPEI。
- PPEI标准可用于识别CTEPH高风险患者,并提示再住院、死亡和生活质量下降风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To systematically assess late outcomes of acute pulmonary embolism (PE) and to investigate the clinical implications of post-PE impairment (PPEI) fulfilling prospectively defined criteria. METHODS AND RESULTS: A prospective multicentre observational cohort study was conducted in 17 large-volume centres across Germany. Adult consecutive patients with confirmed acute symptomatic PE were followed with a standardized assessment plan and pre-defined visits at 3, 12, and 24 months. The co-primary outcomes were (i) diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH), and (ii) PPEI, a combination of persistent or worsening clinical, functional, biochemical, and imaging parameters during follow-up. A total of 1017 patients (45% women, median age 64 years) were included in the primary analysis. They were followed for a median duration of 732 days after PE diagnosis. The CTEPH was diagnosed in 16 (1.6%) patients, after a median of 129 days; the estimated 2-year cumulative incidence was 2.3% (1.2-4.4%). Overall, 880 patients were evaluable for PPEI; the 2-year cumulative incidence was 16.0% (95% confidence interval 12.8-20.8%). The PPEI helped to identify 15 of the 16 patients diagnosed with CTEPH during follow-up (hazard ratio for CTEPH vs. no CTEPH 393; 95% confidence interval 73-2119). Patients with PPEI had a higher risk of re-hospitalization and death as well as worse quality of life compared with those without PPEI. CONCLUSION: In this prospective study, the cumulative 2-year incidence of CTEPH was 2.3%, but PPEI diagnosed by standardized criteria was frequent. Our findings support systematic follow-up of patients after acute PE and may help to optimize guideline recommendations and algorithms for post-PE care.
引用
- Valerio L, Mavromanoli AC, Barco S, et al. Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study. Eur Heart J. 2022. PMID: 35484821. doi:10.1093/eurheartj/ehac206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。